血液系统恶性肿瘤分子发病原理或异常信号途径分型。
Classification of Hematological Malignancies Based on Pathogenesis Molecules or Abnormal Pathways.
目的调查血液系统恶性肿瘤患者医院感染发生率及有关危险因素。
Objective In order to investigate the nosocomial infection rate and risk factors in several malignant tumors of hematopoietic system.
目前多项研究表明TAM与血液系统恶性肿瘤的临床表现及预后相关。
Now several studies have indicated that TAM is related to the clinical manifestations and prognosis of hematologic malignancies.
常规扁桃体切除标本中的隐匿性血液系统恶性肿瘤：单一机构的经验和文献复习。
Occult hematologic malignancy in routine tonsillectomy specimens: a single institutional experience and review of the literature.
针对NOS、COX或两者的选择性抑制剂为血液系统恶性肿瘤的治疗提供了新的线索。
The selective inhibitors of NOS, COX, or the both may provide a new approach for the treatment of hematological malignancies.
目的探讨CD5 9抗原在血液系统恶性肿瘤患者红细胞及成熟粒细胞上的表达及意义。
Objective To explore the expression of CD59 antigen from patients with haematological malignancies and its clinical significance.
流式细胞术已成为诊断血液系统恶性肿瘤不可缺少的工具，广泛应用于白血病的临床检测。
Recently, flow cytometry becomes one of the obbligato tools in the procedure of diagnosis of hematological malignant tumors and has been widely used in clinical test.
血管发生在实体肿瘤及血液系统恶性肿瘤进程中扮演重要角色。血管生成素是其重要的调节因素。
Angiogenesis plays an important role in solid tumors and hematologic malignancies. The angiopoietins act as essential regulators in this process.
多发性骨髓瘤(MM)是一种常见的血液系统恶性肿瘤，主要集中在老年人，40 a以下者少见。
Multiple myeloma (mm) is a common hematological malignant disease with major incidence among old agings and rarely occurs under 40 year old.
目的探讨共刺激分子B7 1 (CD80)在血液系统恶性肿瘤发病学及免疫基因治疗中的重要作用。
Objective to explore the significance of costimulatory molecule B7-1 (CD80) and MHC molecules in the pathogenesis of hematologic malignant tumors and in the immuno-genetic therapy.
其中约三分之一的患者因血液系统恶性肿瘤、癌症高强度化疗或移植后治疗而存在免疫系统严重低下的问题。
Around one third of these cases occurred in patients whose immune systems were severely suppressed by haematological malignancy, aggressive chemotherapy for cancer, or post-transplant treatment.
从细胞生物学及分子生物学水平，立足于中药对机体免疫功能、对血管血液系统、对癌前病变的影响及有关方面探讨了中药抗恶性肿瘤的有关机理。
This paper deals with the mechanisms of the treatment with reference to cytobiology and molecular biology and the effect of Chinese medicine on immunity, the blood system and pathological changes.
目的旨在观察激光量子辐照充氧血液疗法对造血系统恶性肿瘤及血栓性疾病患者自然杀伤细胞活性的影响。
Objective To observe the effects of Laser Blood Quatum therapy on the NK cell activity in hemopoietic system malignant tumor and thrombotic disease.
如果造血细胞或其子代细胞进行恶性性增生，即成为血液系统的恶性肿瘤。
If the hematopoietic cells or their progeny cells are malignant hyperplasia, it becomes the malignancy of blood system.
如果造血细胞或其子代细胞进行恶性性增生，即成为血液系统的恶性肿瘤。
If the hematopoietic cells or their progeny cells are malignant hyperplasia, it becomes the malignancy of blood system.
应用推荐